These mechanisms suggest that GLP-1R agonists help regulate inflammatory and immune responses in vascular smooth muscle cells and may ameliorate the progression of atherosclerosis by modulating the AKT and mTOR signaling pathways. This evidence concerns the gene AKT1 and atherosclerosis.